These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7751022)

  • 21. Regulation of cAMP-responsive enhancer binding proteins during cell cycle progression in T lymphocytes stimulated by IL-2.
    Feuerstein N; Huang D; Hinrichs SH; Orten DJ; Aiyar N; Prystowsky MB
    J Immunol; 1995 Jan; 154(1):68-79. PubMed ID: 7995960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
    Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
    J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the human IgE response.
    de Vries JE; Yssel H
    Eur Respir J Suppl; 1996 Aug; 22():58s-62s. PubMed ID: 8871045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrovirus infection alters growth factor responses of T lymphocytes.
    Lichtman AH; Williams ME; Ohara J; Paul WE; Faller DV; Abbas AK
    J Immunol; 1987 May; 138(10):3276-83. PubMed ID: 3033071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
    Kuznetsov VA; Puri RK
    Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive and anticancer effect of a mammalian ribonuclease that targets high-affinity interleukin-2-receptors.
    Yamamura T; Ueda M; Psarras K; Suwa T; Watanaabe Y; Kameyama N; Tanabe M; Imamura H; Kitajima M
    Eur J Surg; 2002; 168(1):49-54. PubMed ID: 12022372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic AMP suppresses interleukin-5 synthesis by human helper T cells via the downregulation of the calcium mobilization pathway.
    Kaminuma O; Mori A; Ogawa K; Kikkawa H; Nakata A; Ikezawa K; Okudaira H
    Br J Pharmacol; 1999 May; 127(2):521-9. PubMed ID: 10385254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding.
    Yates AJ; VanBrocklyn J; Saqr HE; Guan Z; Stokes BT; O'Dorisio MS
    Exp Cell Res; 1993 Jan; 204(1):38-45. PubMed ID: 8416794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced IL-4-mediated D10.G4.1 proliferation with suboptimal concentrations of anti-IL-4 receptor monoclonal antibodies.
    Lindqvist C; Lundström H; Oker-Blom C; Akerman KE
    J Immunol; 1993 Jan; 150(2):394-8. PubMed ID: 8419473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
    Gooch JL; Lee AV; Yee D
    Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
    Friedrich K; Wietek S
    Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The production of soluble interleukin 4 receptors is preferentially regulated by the murine Th2 cell subset.
    Fernandez-Botran R; Chilton PM; Ma Y; Windsor JL; Street NE
    Cytokine; 1997 Mar; 9(3):166-77. PubMed ID: 9126705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13.
    Serve H; Oelmann E; Herweg A; Oberberg D; Serve S; Reufi B; Mücke C; Minty A; Thiel E; Berdel WE
    Cancer Res; 1996 Aug; 56(15):3583-8. PubMed ID: 8758930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-10 stimulates murine antigen-driven antibody responses in vitro by regulating helper cell subset participation.
    Marcelletti JF; Katz DH
    Cell Immunol; 1996 Jan; 167(1):86-98. PubMed ID: 8548850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane gangliosides modulate interleukin-2-stimulated T-lymphocyte proliferation.
    Sharom FJ; Chiu AL; Chu JW
    Biochim Biophys Acta; 1991 Aug; 1094(1):35-42. PubMed ID: 1832018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
    Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
    Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
    J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor.
    Paliogianni F; Ahuja SS; Balow JP; Balow JE; Boumpas DT
    J Immunol; 1993 Oct; 151(8):4081-9. PubMed ID: 8409387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.